Innovate demonstrates effects of larazotide in NASH preclinical study
Proof of reduced gut permeability with larazotide against the backdrop of diet-induced obesity creates the…
VSBLTY now a part of MGI’s group of firms providing security solutions
Philadelphia-based VSBLTY Groupe Technologies Corp. has reportedly declared that it has established a partnership with…
Chembio’s Point-of-Care Multiplex Test approved by Brazil’s ANVISA
Globally reputed point-of-care diagnostics company, Chembio Diagnostics, Inc., has apparently declared that Brazil’s health regulatory…
CPI partners with AstraZeneca, GSK for pharma manufacturing facility
The facility will help the pharmaceutical industry of UK, as it will prove ideal for…
Versum Materials Inc. accepts superior takeover proposal by Merck
With the proposed acquisition, Merck intends to expand its presence across the semiconductor materials market…
Genkyotex to showcase updated interim results of GKT831 Phase 2 trial
Genkyotex, a biopharmaceutical firm and recognized provider of NOX therapies, has recently declared that it…
Myriad expands companion diagnostic alliance with AstraZeneca & Merck
Myriad intends to file an additional premarket approval application with U.S. Food and Drug Administration…
Oxurion NV declares full enrollment of its THR-317 Phase II trial
Oxurion NV, a biopharmaceutical firm engaged in creating pioneering treatments to protect vision in people…
Realme to set up more outlets across India to boost offline sales
Realme’s smartphones were up for sale in Coimbatore’s top 100 retail outlets. Realme, one of…